DE69115687D1 - Verwendung von spezifischen Fettsäuren zur Herstellung eines Medikaments zur Verabreichung durch Iontophorese - Google Patents

Verwendung von spezifischen Fettsäuren zur Herstellung eines Medikaments zur Verabreichung durch Iontophorese

Info

Publication number
DE69115687D1
DE69115687D1 DE69115687T DE69115687T DE69115687D1 DE 69115687 D1 DE69115687 D1 DE 69115687D1 DE 69115687 T DE69115687 T DE 69115687T DE 69115687 T DE69115687 T DE 69115687T DE 69115687 D1 DE69115687 D1 DE 69115687D1
Authority
DE
Germany
Prior art keywords
fatty acids
iontophoresis
medicament
administration
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69115687T
Other languages
English (en)
Other versions
DE69115687T2 (de
Inventor
Rama Padmanabhan
Joan Sunram
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of DE69115687D1 publication Critical patent/DE69115687D1/de
Application granted granted Critical
Publication of DE69115687T2 publication Critical patent/DE69115687T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69115687T 1990-04-18 1991-04-15 Verwendung von spezifischen Fettsäuren zur Herstellung eines Medikaments zur Verabreichung durch Iontophorese Expired - Lifetime DE69115687T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51050290A 1990-04-18 1990-04-18
PCT/US1991/002569 WO1991016077A1 (en) 1990-04-18 1991-04-15 Improved method to administer drugs by iontophoresis

Publications (2)

Publication Number Publication Date
DE69115687D1 true DE69115687D1 (de) 1996-02-01
DE69115687T2 DE69115687T2 (de) 1996-07-18

Family

ID=24031010

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69115687T Expired - Lifetime DE69115687T2 (de) 1990-04-18 1991-04-15 Verwendung von spezifischen Fettsäuren zur Herstellung eines Medikaments zur Verabreichung durch Iontophorese

Country Status (16)

Country Link
EP (1) EP0525063B1 (de)
JP (1) JP3261501B2 (de)
AT (1) ATE131733T1 (de)
AU (1) AU650879B2 (de)
CA (1) CA2078998A1 (de)
DE (1) DE69115687T2 (de)
DK (1) DK0525063T3 (de)
ES (1) ES2081476T3 (de)
FI (1) FI924724A (de)
GR (1) GR3018883T3 (de)
IE (1) IE73245B1 (de)
NO (1) NO924029L (de)
NZ (1) NZ237489A (de)
PT (1) PT97410B (de)
WO (1) WO1991016077A1 (de)
ZA (1) ZA912192B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0804155B1 (de) * 1994-07-13 2000-11-08 Alza Corporation Zusammensetzung und verfahren zur förderung von transdermaler elektrotransport-darreichung
US5990179A (en) * 1995-04-28 1999-11-23 Alza Corporation Composition and method of enhancing electrotransport agent delivery
US5985316A (en) * 1995-04-28 1999-11-16 Alza Corporation Composition and method of enhancing electrotransport agent delivery
DE19816143A1 (de) 1998-04-09 1999-10-21 Fischer Wilfried Transdermales Applikationssystem (TDS) mit Elektrodenraster
US6757560B1 (en) 1999-04-09 2004-06-29 Novosis Pharma Ag Transdermal delivery system (TDS) with electrode network
EP1457233B1 (de) 2003-03-12 2007-07-11 Novosis AG Transdermales Wirkstoffverabreichungssystem mit Elektrodenraster
DE102007020799A1 (de) 2007-05-03 2008-11-06 Novosis Ag Transdermales therapeutisches System mit Remifentanil
DE102007021549A1 (de) 2007-05-08 2008-11-13 Novosis Ag Transdermales therapeutisches System enthaltend mindestens zwei Opioide
DE102007058504A1 (de) 2007-12-05 2009-07-09 Acino Ag Transdermales therapeutisches System mit einem Gehalt an einem Modulator für nikotinische Acetylcholinrezeptoren (nAChR)
DE102010024558B4 (de) 2010-06-22 2016-04-21 Amw Gmbh Transdermales therapeutisches System mit Elektroden
CN115436538B (zh) * 2022-09-17 2023-08-01 山东省计量科学研究院 一种肉类食品基体兽药残留标准物质制备装置与方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
JPH02503672A (ja) * 1987-06-01 1990-11-01 ワーナー‐ランバート・コンパニー 水性の系における浸透促進剤としての脂肪酸およびその短鎖エステル
EP0351897A3 (de) * 1988-06-17 1990-03-21 The Procter & Gamble Company Hautpenetrierendes System für aminfunktionelle Anrzneistoffsalze

Also Published As

Publication number Publication date
FI924724A0 (fi) 1992-10-19
PT97410B (pt) 1998-08-31
ZA912192B (en) 1992-01-29
AU650879B2 (en) 1994-07-07
DE69115687T2 (de) 1996-07-18
CA2078998A1 (en) 1991-10-19
JPH05506232A (ja) 1993-09-16
JP3261501B2 (ja) 2002-03-04
FI924724A (fi) 1992-10-19
ATE131733T1 (de) 1996-01-15
WO1991016077A1 (en) 1991-10-31
IE73245B1 (en) 1997-05-21
NO924029D0 (no) 1992-10-16
AU7750091A (en) 1991-11-11
EP0525063B1 (de) 1995-12-20
GR3018883T3 (en) 1996-05-31
NO924029L (no) 1992-10-16
DK0525063T3 (da) 1996-01-29
PT97410A (pt) 1992-01-31
NZ237489A (en) 1995-07-26
IE911280A1 (en) 1991-10-23
EP0525063A1 (de) 1993-02-03
ES2081476T3 (es) 1996-03-16

Similar Documents

Publication Publication Date Title
ATE122899T1 (de) Verfahren und gegenstand zur transdermalen administration von dexmedetomidin.
SE8703625D0 (sv) New medical use
SE8404243D0 (sv) Forfarande och anordning for elektro-terapeutisk behandling
DE3587941D1 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
ES550011A0 (es) Un metodo de administracion de una cantidad terapeuticamenteefectiva de timolol
ATE94380T1 (de) Anti-akne-zusammensetzung.
DE3585618D1 (de) Anregung zur heilung einer wunde mittels menschlichen hautwachstumsfaktors hergestellt durch rekombinant-dns.
ATE119772T1 (de) Bilobalid zur anwendung als therapeutischer wirkstoff.
DE69115687D1 (de) Verwendung von spezifischen Fettsäuren zur Herstellung eines Medikaments zur Verabreichung durch Iontophorese
DE3667610D1 (de) System zur verabreichung von substanzen durch die haut.
ATE109357T1 (de) Transdermales estradiol als therapeutisches sytem.
PT87345A (pt) Processo para a fabricacao de um emplastro para a administracao controlada de substancias activas a pele
FI95653C (fi) Menetelmä lääkeaineen anto- ja/tai annostelumuodon valmistamiseksi
AU7426487A (en) Method of treating depression using d-fenfluramine
DE69110615D1 (de) Verwendung von Aminosäuren zum Schutz von ischemischem Herzgewebe und dessen metabolischer Wiederherstellung.
AR003979A1 (es) Administracion transdermica de vorozol.
DK131586A (da) Transdermalt, antiallergisk, farmaceutisk praeparat
ATE86105T1 (de) Verwendung von probucol zur herstellung eines arzneimittels fuer die behandlung von herzarrhythmie.
ATE28384T1 (de) Medizinisches verfahren und zubereitung.
ATE72115T1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-
DE3574675D1 (de) Verfahren zum sterilisieren von rekombinantem mikroorganismus.
ATE64539T1 (de) Dermale und transdermale therapeutische systeme mit musterfoermig aufgetragener klebschicht, sowie verfahren zur dessen herstellung.
ATE58831T1 (de) Verwendung von dicarbonsaeuren mit 7-13 kohlenstoffatomen oder physiologisch vertraeglichen salzen davon zur herstellung eines arzneimittels zur topischen behandlung von rosazea.
DE69430807D1 (de) Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen
UA28769A (uk) Спосіб лікування променевих ушкоджень шкіри

Legal Events

Date Code Title Description
8364 No opposition during term of opposition